Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy

Purpose. To compare the incidence of breast cancer (BC) relapse after subcutaneous mastectomy and Madden radical mastectomy.Patients and methods. The study included 102 patients diagnosed with BC with stages IIB – III, who underwent neoadjuvant drug therapy with a subsequent surgical stage of treatm...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Yu. Rykov, D. A. Maksimov
Format: Article
Language:Russian
Published: QUASAR, LLC 2023-03-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/775
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524336387686400
author M. Yu. Rykov
D. A. Maksimov
author_facet M. Yu. Rykov
D. A. Maksimov
author_sort M. Yu. Rykov
collection DOAJ
description Purpose. To compare the incidence of breast cancer (BC) relapse after subcutaneous mastectomy and Madden radical mastectomy.Patients and methods. The study included 102 patients diagnosed with BC with stages IIB – III, who underwent neoadjuvant drug therapy with a subsequent surgical stage of treatment on the basis of the Tver Regional Clinical Oncology Dispensary from 2017 to 2020. The main group included 50 patients who underwent subcutaneous mastectomy with simultaneous installation of an endoprosthesis: stage IIB – 31 (62 %) patients; stage III – 19 (38 %) patients. The comparison group included 52 patients who underwent surgical treatment in volume – radical mastectomy according to Madden (RME): Stage IIB – 34 (65.4 %) patients; stage III – 18 (34.6 %) patients. Depending on the subtype of the tumor, patients received neoadjuvant drug therapy.Results. During the three-year follow-up period, the progression of the disease after subcutaneous RME was detected in 7 (14 %) patients. Locoregional relapses accounted for 4 cases (8 %), progression to distant organs 3 cases (6 %). After the Madden RME, disease progression was detected in 6 (11.5 %) patients. Locoregional relapses accounted for 3 cases (5.7 %), progression to distant organs 3 cases (5.7 %). The detected foci did not always coincide with the primary subtype of the tumor: in 5 cases the subtype was different (38.5 %), in 8 cases it coincided (61.5 %).Conclusion. The frequency of development of locoregional and distant metastases did not statistically depend on the volume of surgical intervention (p > 0.05). It is reasonable to conduct a histological examination in case of progression to determine the tactics of treatment.
format Article
id doaj-art-389b6abfe5d64c09ba0b00fbf03d4ec0
institution Kabale University
issn 2410-1893
language Russian
publishDate 2023-03-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-389b6abfe5d64c09ba0b00fbf03d4ec02025-02-03T07:12:17ZrusQUASAR, LLCИсследования и практика в медицине2410-18932023-03-01101505610.17709/2410-1893-2023-10-1-4481Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapyM. Yu. Rykov0D. A. Maksimov1Russian State Social University; N.A. Semashko National Research Institute of Public HealthTver Regional Clinical Oncological DispensaryPurpose. To compare the incidence of breast cancer (BC) relapse after subcutaneous mastectomy and Madden radical mastectomy.Patients and methods. The study included 102 patients diagnosed with BC with stages IIB – III, who underwent neoadjuvant drug therapy with a subsequent surgical stage of treatment on the basis of the Tver Regional Clinical Oncology Dispensary from 2017 to 2020. The main group included 50 patients who underwent subcutaneous mastectomy with simultaneous installation of an endoprosthesis: stage IIB – 31 (62 %) patients; stage III – 19 (38 %) patients. The comparison group included 52 patients who underwent surgical treatment in volume – radical mastectomy according to Madden (RME): Stage IIB – 34 (65.4 %) patients; stage III – 18 (34.6 %) patients. Depending on the subtype of the tumor, patients received neoadjuvant drug therapy.Results. During the three-year follow-up period, the progression of the disease after subcutaneous RME was detected in 7 (14 %) patients. Locoregional relapses accounted for 4 cases (8 %), progression to distant organs 3 cases (6 %). After the Madden RME, disease progression was detected in 6 (11.5 %) patients. Locoregional relapses accounted for 3 cases (5.7 %), progression to distant organs 3 cases (5.7 %). The detected foci did not always coincide with the primary subtype of the tumor: in 5 cases the subtype was different (38.5 %), in 8 cases it coincided (61.5 %).Conclusion. The frequency of development of locoregional and distant metastases did not statistically depend on the volume of surgical intervention (p > 0.05). It is reasonable to conduct a histological examination in case of progression to determine the tactics of treatment.https://www.rpmj.ru/rpmj/article/view/775oncologybreast cancerradical mastectomysubcutaneous radical mastectomyskin-preserving mastectomylocoregional recurrence
spellingShingle M. Yu. Rykov
D. A. Maksimov
Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
Исследования и практика в медицине
oncology
breast cancer
radical mastectomy
subcutaneous radical mastectomy
skin-preserving mastectomy
locoregional recurrence
title Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
title_full Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
title_fullStr Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
title_full_unstemmed Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
title_short Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
title_sort analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
topic oncology
breast cancer
radical mastectomy
subcutaneous radical mastectomy
skin-preserving mastectomy
locoregional recurrence
url https://www.rpmj.ru/rpmj/article/view/775
work_keys_str_mv AT myurykov analysisofthebreastcancerprogressionfrequencydependingontheamountofsurgicaltreatmentperformedafterneoadjuvantdrugtherapy
AT damaksimov analysisofthebreastcancerprogressionfrequencydependingontheamountofsurgicaltreatmentperformedafterneoadjuvantdrugtherapy